These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

640 related items for PubMed ID: 17090719

  • 21. Diagnostic accuracy of nodal enhancement pattern of rectal cancer at MRI enhanced with ultrasmall superparamagnetic iron oxide: findings in pathologically matched mesorectal lymph nodes.
    Koh DM, George C, Temple L, Collins DJ, Toomey P, Raja A, Bett N, Farhat S, Husband JE, Brown G.
    AJR Am J Roentgenol; 2010 Jun; 194(6):W505-13. PubMed ID: 20489069
    [Abstract] [Full Text] [Related]

  • 22. Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging.
    de Bondt RB, Nelemans PJ, Hofman PA, Casselman JW, Kremer B, van Engelshoven JM, Beets-Tan RG.
    Eur J Radiol; 2007 Nov; 64(2):266-72. PubMed ID: 17391885
    [Abstract] [Full Text] [Related]

  • 23. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
    Deserno WM, Harisinghani MG, Taupitz M, Jager GJ, Witjes JA, Mulders PF, Hulsbergen van de Kaa CA, Kaufmann D, Barentsz JO.
    Radiology; 2004 Nov; 233(2):449-56. PubMed ID: 15375228
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Magnetic resonance imaging diagnosis of metastatic lymph nodes in a rabbit model: efficacy of PJY10, a new ultrasmall superparamagnetic iron oxide agent, with monodisperse iron oxide core and multiple-interaction ligands.
    Yoo RE, Choi SH, Cho HR, Jeon BS, Kwon E, Kim EG, Park J, Myeong WJ, Won JK, Lee YS, Kim JH, Park SW, Sohn CH.
    PLoS One; 2014 Nov; 9(9):e107583. PubMed ID: 25216040
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography.
    Bellin MF, Lebleu L, Meric JB.
    Abdom Imaging; 2003 Nov; 28(2):155-63. PubMed ID: 12592461
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of lymph node metastases in gastric cancer using magnetic resonance imaging with ultrasmall superparamagnetic iron oxide (USPIO): diagnostic performance in post-contrast images using new diagnostic criteria.
    Tokuhara T, Tanigawa N, Matsuki M, Nomura E, Mabuchi H, Lee SW, Tatsumi Y, Nishimura H, Yoshinaka R, Kurisu Y, Narabayashi I.
    Gastric Cancer; 2008 Nov; 11(4):194-200. PubMed ID: 19132480
    [Abstract] [Full Text] [Related]

  • 29. Possible pathological basis for false diagnoses of lymph nodes by USPIO-enhanced MRI in rabbits.
    Lei J, Xue HD, Li Z, Li S, Jin ZY.
    J Magn Reson Imaging; 2010 Jun; 31(6):1428-34. PubMed ID: 20512896
    [Abstract] [Full Text] [Related]

  • 30. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes?
    Lahaye MJ, Beets GL, Engelen SM, Kessels AG, de Bruïne AP, Kwee HW, van Engelshoven JM, van de Velde CJ, Beets-Tan RG.
    Radiology; 2009 Jul; 252(1):81-91. PubMed ID: 19403848
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation.
    Harisinghani MG, Saini S, Weissleder R, Hahn PF, Yantiss RK, Tempany C, Wood BJ, Mueller PR.
    AJR Am J Roentgenol; 1999 May; 172(5):1347-51. PubMed ID: 10227514
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Use of ultrasmall superparamagnetic iron oxide in lymph node MR imaging in prostate cancer patients.
    Barentsz JO, Fütterer JJ, Takahashi S.
    Eur J Radiol; 2007 Sep; 63(3):369-72. PubMed ID: 17689215
    [Abstract] [Full Text] [Related]

  • 36. Detection of lymph node metastases with ultrasmall superparamagnetic iron oxide (USPIO)-enhanced magnetic resonance imaging in oesophageal cancer: a feasibility study.
    Pultrum BB, van der Jagt EJ, van Westreenen HL, van Dullemen HM, Kappert P, Groen H, Sietsma J, Oudkerk M, Plukker JT, van Dam GM.
    Cancer Imaging; 2009 Apr 06; 9(1):19-28. PubMed ID: 19414293
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide.
    Nishimura H, Tanigawa N, Hiramatsu M, Tatsumi Y, Matsuki M, Narabayashi I.
    J Am Coll Surg; 2006 Apr 06; 202(4):604-11. PubMed ID: 16571430
    [Abstract] [Full Text] [Related]

  • 39. Lymph node metastases from gastric cancer: gadofluorine M and gadopentetate dimeglumine MR imaging in a rabbit model.
    Lee JY, Choi BI, Son KR, Lee JM, Kim SJ, Park HS, Chang JM, Choi SH, Kim MA, Moon WK.
    Radiology; 2012 May 06; 263(2):391-400. PubMed ID: 22517957
    [Abstract] [Full Text] [Related]

  • 40. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging.
    Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ.
    Radiology; 1990 May 06; 175(2):494-8. PubMed ID: 2326475
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.